Luma Health Co Tirzepatide Review: Four-Week Prices & Terms

Luma Health Co publishes tirzepatide prices for a four-week supply, ranging from $180 to $275 across its listed strength labels. Its FAQ says there are no monthly subscriptions, monthly fees or points. A medication price list still needs to be matched to the prescribed plan, consultation charges and delivery arrangements before payment.^3,4

The Livea review examines conflicting descriptions of a program fee and separately billed medication. Compare the itemized care and drug charges, rather than assuming that a monthly figure covers the same services as a medication supply list.

The Potere Health MD review examines posted-total wording alongside a separately billed pharmacy component. Ask how the clinic and pharmacy portions appear on the invoice before comparing services that advertise no required membership.

Compare four-week supplies, not a universal monthly rate

The pricing page lists 2.5 mg at $180, 5 mg at $205, 7.5 mg at $215, 10 mg at $235, 12.5 mg at $255 and 15 mg at $275, each labeled as a four-week supply. These are public menu labels, not instructions to select or change a dose. The clinician must determine the actual prescription, concentration, quantity and administration instructions.³

Four weeks is not a calendar month. The $180 entry is also not the price at every listed strength. Ask for the total for the prescribed supply, any consultation or follow-up charge, shipping and laboratory costs, and when a further order would be needed. The published medication table does not by itself establish that every additional service is included.³

The NiceRx review provides a different four-week arrangement: $249 billed every four weeks, with longer prepaid plans defined as twelve, twenty-four or forty-eight weeks. Unlike a four-week supply list without monthly subscriptions, that menu also specifies billing intervals. Compare both the supplied weeks and renewal schedule before treating a plan labeled monthly or yearly as a calendar-period bill.¹⁰

No subscription does not mean every payment is refundable

The FAQ expressly says Luma does not offer monthly subscriptions or monthly fees. It also says insurance is not accepted, while credit/debit cards, HSA/FSA funds and selected financing options are described. Financing availability is not a promise of approval, and acceptance of an HSA/FSA payment method is not a guarantee of reimbursement or tax treatment.⁴

Luma’s linked Terms, effective June 24, 2026, describe fees disclosed at purchase or service delivery as final and generally nonrefundable. They authorize charges for services rendered and applicable taxes or fees. The public document does not establish a complete medication-specific cancellation cutoff, refund rule when treatment is declined, or a guaranteed shipping-charge inclusion. Request those purchase-specific details before paying.⁵

A pay-per-order arrangement removes the subscription question but leaves the amount due, refill authorization and order-processing status important. Ask whether an evaluation is billed separately and what happens financially if the clinician recommends a different treatment or no prescription.

The exact clinic and its public disclosures

This review concerns Luma Health Co on its own lumahealthco domain. Its About page names Tiffani McKnight, FNP-C, and the site footer publishes a Louisiana nurse-practitioner identifier and a Livingston, Louisiana contact address. These are the clinic’s disclosures, not independent verification of a current license, certification or authority to treat someone in a particular state.^3,6

The homepage lists states and Washington, DC, while the FAQ directs readers to that list. Confirm service at your physical location and the actual clinician before an appointment. A published state list or named founder does not establish personal eligibility or that every treatment is offered in every listed jurisdiction.^4,7

What the telehealth documents establish

The Terms say a provider–patient relationship begins only after acceptance through clinical intake and confirmation of care. The separate telehealth-consent form describes remote consultations and their limitations. Reading those public documents is not the same as accepting an individual care agreement or completing an evaluation.^5,8

Ask for the preparing and dispensing pharmacy, the exact formulation and supply, and the prescription’s follow-up arrangements. The practical comparison is the full four-week cost and actual clinical plan, not a low entry on a medication table or an assumption that no subscription means no other charges.

Earlier network descriptions need the same check. The Silhouette MD review records an October 22 check that did not reconfirm its offer or an earlier claim about OpenLoop. That limitation does not establish closure, but it means an old network name cannot identify today’s prescriber or dispenser. Confirm the current arrangement rather than transferring another clinic’s disclosures.¹¹

The medicine is separate from the platform

Compounded tirzepatide is not an FDA-approved finished drug.⁹ SURMOUNT-1 and SURMOUNT-5 studied specific tirzepatide products and protocols, not this platform’s compounded preparation, service or testimonials. Those trials provide background about the medicine; they do not establish the platform’s results or the equivalence of oral and injectable formulations.^1,2 A clinician must assess the individual prescription and explain its risks, alternatives and instructions.

Further reading

whether compounded tirzepatide is still legal in 2026 · Zepbound side effects · the gallbladder risk · thyroid cancer warning · tirzepatide evidence guide · Livea · Potere Health MD · best tirzepatide providers